• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Heron Therapeutics

Anonymous board for Heron Therapeutics
Replies
3
Views
221
anonymous
Replies
12
Views
2K
anonymous
Replies
21
Views
8K
anonymous
Replies
5
Views
2K
anonymous
Replies
9
Views
2K
anonymous
Replies
7
Views
2K
anonymous
Replies
7
Views
3K
anonymous
Replies
5
Views
3K
anonymous
Replies
2
Views
1K
anonymous
Replies
17
Views
5K
anonymous
Replies
8
Views
2K
anonymous
Replies
4
Views
1K
anonymous
Replies
6
Views
3K
anonymous
Replies
3
Views
2K
anonymous
Replies
2
Views
2K
anonymous
Replies
37
Views
9K
anonymous
Replies
1
Views
1K
anonymous
Replies
6
Views
2K
anonymous